397 related articles for article (PubMed ID: 22131939)
1. Oxidative stress in schizophrenia.
Bošković M; Vovk T; Kores Plesničar B; Grabnar I
Curr Neuropharmacol; 2011 Jun; 9(2):301-12. PubMed ID: 22131939
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant treatments for schizophrenia.
Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol.
Bošković M; Vovk T; Koprivšek J; Plesničar BK; Grabnar I
Nutr Neurosci; 2016 May; 19(4):156-61. PubMed ID: 25056532
[TBL] [Abstract][Full Text] [Related]
5. Free radicals, antioxidant defense systems, and schizophrenia.
Wu JQ; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.
Mahadik SP; Evans D; Lal H
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):463-93. PubMed ID: 11370992
[TBL] [Abstract][Full Text] [Related]
7. Polyunsaturated fatty acid supplementation for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
[TBL] [Abstract][Full Text] [Related]
8. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
Mahadik SP; Pillai A; Joshi S; Foster A
Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
[TBL] [Abstract][Full Text] [Related]
9. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
Essali A; Soares-Weiser K; Bergman H; Adams CE
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
[TBL] [Abstract][Full Text] [Related]
11. [Oxidative stress involvement in schizophrenia pathophysiology: a review].
Fendri C; Mechri A; Khiari G; Othman A; Kerkeni A; Gaha L
Encephale; 2006; 32(2 Pt 1):244-52. PubMed ID: 16910626
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Lykkesfeldt J
Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
[TBL] [Abstract][Full Text] [Related]
15. Antioxidants for female subfertility.
Showell MG; Brown J; Clarke J; Hart RJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD007807. PubMed ID: 23913583
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
McGrath JJ; Soares KV
Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
[TBL] [Abstract][Full Text] [Related]
17. A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia.
Solberg DK; Refsum H; Andreassen OA; Bentsen H
Acta Neuropsychiatr; 2019 Aug; 31(4):202-212. PubMed ID: 31178002
[TBL] [Abstract][Full Text] [Related]
18. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
Soares-Weiser KV; Joy C
Cochrane Database Syst Rev; 2003; (2):CD000208. PubMed ID: 12804390
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
Soares-Weiser K; Rathbone J
Cochrane Database Syst Rev; 2004; (1):CD000206. PubMed ID: 14973950
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant micronutrients for lung disease in cystic fibrosis.
Shamseer L; Adams D; Brown N; Johnson JA; Vohra S
Cochrane Database Syst Rev; 2010 Dec; (12):CD007020. PubMed ID: 21154377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
